000 01499 a2200433 4500
005 20250517095841.0
264 0 _c20180503
008 201805s 0 0 eng d
022 _a1399-3003
024 7 _a10.1183/13993003.01918-2015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChassagnon, Guillaume
245 0 0 _aLong-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor.
_h[electronic resource]
260 _bThe European respiratory journal
_c07 2016
300 _a249-52 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdult
650 0 4 _aAminophenols
_xtherapeutic use
650 0 4 _aChloride Channel Agonists
_xtherapeutic use
650 0 4 _aCystic Fibrosis
_xdiagnostic imaging
650 0 4 _aCystic Fibrosis Transmembrane Conductance Regulator
_xgenetics
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aFemale
650 0 4 _aFrance
650 0 4 _aHumans
650 0 4 _aLung
_xdiagnostic imaging
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aQuinolones
_xtherapeutic use
650 0 4 _aRetrospective Studies
650 0 4 _aTime
650 0 4 _aTomography, X-Ray Computed
_xmethods
700 1 _aHubert, Dominique
700 1 _aFajac, Isabelle
700 1 _aBurgel, Pierre-Régis
700 1 _aRevel, Marie-Pierre
773 0 _tThe European respiratory journal
_gvol. 48
_gno. 1
_gp. 249-52
856 4 0 _uhttps://doi.org/10.1183/13993003.01918-2015
_zAvailable from publisher's website
999 _c26063665
_d26063665